Equities research analysts at Wedbush upped their Q1 2025 earnings estimates for shares of Fennec Pharmaceuticals in a ...

Q4 2024 Earnings Call Transcript March 10, 2025 Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year.

The main point of investing for the long term is to make money. But more than that, you probably want to see it ...

FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results on Monday, March 10th. The company reported earnings of -$0.06 per share, missing estimates of $0.17 ...

Reports Q4 revenue $7.93M, consensus $16.42M. “2024 marked the beginning of a foundational transformation for Fennec (FENC), setting the stage ...

Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Fennec Pharmaceuticals (FENC – Research Report) today. The company’s shares ...

RESEARCH TRIANGLE PARK, N.C., March 10, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today reported its financial results for the ...

Analysts at HC Wainwright upped their Q1 2025 EPS estimates for Fennec Pharmaceuticals in a report issued on Tuesday, March ...

Good morning ladies and gentlemen, and welcome to Fennec Pharmaceuticals fourth quarter and full year 2024 earnings and corporate update conference call. (Operator Instructions) As a reminder, today's ...

Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Fourth Quarter and Full Year 2024 Earnings and Corporate Update Conference Call. At this time, all participants are in a ...